Atlas Trials

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Clinical trial NCT04660045 · WITHDRAWN

Trial details

NCT number
NCT04660045
Sponsor
Weill Medical College of Cornell University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaCLL/SLL
Start date
2022-05-01
Primary completion
2026-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.